Why the setting matters

Spravato can cause sedation, dissociation, increased blood pressure, and other side effects that require monitoring. Patients remain in the clinic after dosing and leave only after the care team determines they are clinically stable.

What to know about at-home ketamine

The FDA has identified safety concerns related to compounded ketamine products used for psychiatric conditions, including abuse and misuse, psychiatric events, increased blood pressure, respiratory depression, and urinary or bladder symptoms. Safety concerns may be greater when treatment occurs without direct monitoring by a healthcare provider.

What in-clinic Spravato adds

  • Certified healthcare setting requirements.
  • Direct observation during administration.
  • At least two hours of monitoring after dosing.
  • Blood pressure and side-effect review.
  • Clear transportation instructions after each visit.
  • Insurance and Medicaid review for eligible patients.

Clinical references reviewed: SPRAVATO REMS and the FDA prescribing information. Last reviewed May 2026. This information does not replace a clinical evaluation.

Active Nao Medical Spravato locations

Queens

Astoria

37-15 23rd Ave, Astoria, NY 11105

A western Queens option for patients who want easier access than crossing into Manhattan for every monitored treatment day.

View location details

Bronx

Bartow

2063A Bartow Ave, Bronx, NY 10475

A Bronx access point for patients who want local Spravato care without leaving the borough.

View location details

Long Island

Hicksville

232 W Old Country Rd, Hicksville, NY 11801

A central Nassau option for patients who need consistent follow-up, prior auth support, and a shorter commute.

View location details

Queens

Jamaica

90-18 Sutphin Blvd, Jamaica, NY 11435

A southeast Queens location that helps patients stay on schedule for repeated monitored sessions.

View location details

Queens

Long Island City

30-07 36th Ave, Astoria, NY 11106

A western Queens access point for patients balancing treatment days with work, home, or Manhattan commutes.

View location details

Long Island

Mineola

135 Mineola Blvd, Mineola, NY 11501

A Long Island access point for patients who want strong benefits support and reliable treatment coordination.

View location details

Manhattan

StuyTown

259 1st Ave, New York, NY 10003

A Manhattan Spravato access point for East Village, Gramercy, Kips Bay, and nearby neighborhoods.

View location details

Brooklyn

Williamsburg

308 Graham Ave, Brooklyn, NY 11211

The lead Brooklyn Spravato location for patients who want local access and ongoing psychiatric support.

View location details

Insurance Plans We Accept

Accepted plans can vary by eligibility and authorization rules. This list reflects the insurance access Nao Medical can review for eligible Spravato patients, including Medicaid, Medicare, Medicare Advantage, and commercial coverage options.

  • Molina Healthcare of New York
  • Healthfirst
  • MetroPlus
  • Blue Cross Blue Shield
  • Aetna
  • Fidelis of NY Medicaid
  • Healthfirst Medicaid
  • United Healthcare
  • Medicaid
  • Empire BCBS HealthPlus
  • Medicare
  • 1199 National Benefit Funds
  • Fidelis Care New York
  • United Healthcare Community Plan
  • Cigna
  • Emblem Health
  • GHI - Primary
  • BCBS Anthem

Frequently asked questions

Can Spravato be mailed to my home?

No. Spravato is not dispensed directly to patients for home use.

Is at-home ketamine FDA-approved for depression?

Compounded ketamine products used for psychiatric conditions are not FDA-approved for those uses. Patients should discuss risks and alternatives with a qualified clinician.

Why do Spravato patients stay after treatment?

Monitoring helps the care team watch for sedation, dissociation, blood pressure changes, and other side effects before a patient leaves.

Can I use insurance for Spravato?

Insurance and Medicaid can be reviewed for eligible patients. Coverage depends on benefits, diagnosis, authorization, and plan rules.